- Macular oedema (retinal vein occlusion) - ranibizumab
- Ovarian, fallopian tube and primary peritoneal cancer (recurrent advanced, platinum-sensitive or partially platinum-sensitive) - bevacizumab
- Social anxiety disorder
- Schizophrenia or bipolar disorder - loxapine inhalation (terminated appraisal)
- Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer
No hay comentarios:
Publicar un comentario